08:30-09:15
- Satellite Symposium 2:
- Pfizer Korea46
- Venue: RM 1(Vista 1+2)
Moderators
- Yee Soo Chae
- (Kyungpook National Univ. Chilgok Hospital, Korea)
Speakers
- Palbociclib: Added Value of Long-term Efficacy, Safety and Real-world Data
- Kyung-Hun Lee
- (Seoul National Univ. Hospital, Korea)
09:30-10:15
- Plenary Lecture 3
- 3
- Venue: RM 1(Vista 1+2)
Moderators
- Gyungyub Gong
- (ASAN Medical Center, Korea)
Speakers
- Genomic Biology of Triple Negative Breast Cancer
- Edison Liu
- (The Jackson Laboratory, U.S.A.)
10:30-11:45
- Education Session 4:
- Update of HER2+ Breast Cancer Treatment24
- Venue: RM 3(Walker Hall 1)
Moderators
- Kyung Hae Jung
- (ASAN Medical Center, Korea)
- Makiko Ono
- (The Cancer Institute Hospital of JFCR, Japan)
Speakers
- Systemic Treatment for HER2-positive Early Breast Cancer
- Jee Hung Kim
- (Yonsei Univ. College of Medicine, Korea)
- Systemic Treatment for HER2-positive Metastatic Breast Cancer
- Soo Chin Lee
- (National Univ. Cancer Institute, Singapore)
- Overview and Management of Adverse Events of Anti-HER2 ADCs
- Makiko Ono
- (The Cancer Institute Hospital of JFCR, Japan)
- Symposium 5:
- Single Cell Proteogenomic and Translational Research in Breast Cancer10
- Venue: RM 1(Vista 1+2)
Moderators
- Eugene C. Yi
- (Seoul National Univ.
, Korea)
- Andi Cani
- (Univ. of Michigan, U.S.A.)
Speakers
- Single Cell Genomics in Breast Cancer
- Amos Lee
- (Seoul National Univ., Korea)
- Single Cell Proteomic Technology and Future
- Junho Park
- (CHA Univ. College of Medicine, Korea)
- Single Cell Genomics of Circulating Tumor Cells in Breast Cancer
- Andi Cani
- (Univ. of Michigan, U.S.A.)
- Panel Discussion 4:
- Treatment Dilemma in the Management of Breast Cancer18
- Venue: RM 2(Vista 3)
Moderators
- Sung Gwe Ahn
- (Gangnam Severance Hospital, Korea)
- Mehra Golshan
- (Yale School of Medicine, U.S.A.)
Speakers
- Clinical Staging in Breast Cancer Patients Undergoing Neoadjuvant Treatment
- Han-Byoel Lee
- (Seoul National Univ. Hospital, Korea)
- Can cT3/4 Breast Cancer be Safely Treated with Breast Conserving Surgery After Neoadjuvant Treatment?
- Mehra Golshan
- (Yale School of Medicine, U.S.A.)
- Is Sentinel LN Biopsy Feasible in Clinical N2-3 Patients After Neoadjuvant Treatment?
- Jean-Francois Boileau
- (Jewish General Hospital, McGill Univ., Canada)
- Oral Presentation 5
- 55
- Venue: RM 4(Walker Hall 2)
Moderators
- Jai Min Ryu
- (Samsung Medical Center, Korea)
- Taeryool Koo
- (Hallym Univ. Sacred Heart Hospital, Korea)
- Nursing Session 1 (Kor.):
- The Managements for Cognitive Impairment Related to Breast Cancer33
- Venue: RM 5(Art Hall)
Moderators
- Eun-Young Jun
- (Daejeon Univ., Korea)
- Nayeon Kim
- (Samsung Medical Center, Korea)
Speakers
- The Impact of Chemotherapy on Cognitive Impairments: Evidence and Implications
- Hee-Ju Kim
- (The Catholic Univ. of Korea, Korea)
- The Cognitive Impairment in Breast Cancer Patients Undergoing Therapy
- Hyejin Cho
- (Ewha Womans Univ. Seoul Hospital, Korea)
- Beneficial Effects of Exercise on Cancer-related Cognitive Impairment with Breast Cancer Patients
- Seung-Soo Baek
- (Sangmyung Univ., Korea)
12:00-12:45
- Plenary Lecture 4
- 4
- Venue: RM 1(Vista 1+2)
Moderators
- In Ah Kim
- (Seoul National Univ. Bundang Hospital, Korea)
Speakers
- Breast-Cancer Related Lymphedema: Myths, Facts, Risk Factors and New Approach
- Alphonse Taghian
- (Massachusetts General Hospital, U.S.A.)
13:00-13:45
- Satellite Symposium 3:
- Lilly Korea47
- Venue: RM 1(Vista 1+2)
Moderators
- Jin Seok Ahn
- (Samsung Medical Center, Korea)
Speakers
- Take Hope Further for HR+HER2-high-risk Early Breast Cancer Patients with Abemaciclib
- Nadia Harbeck
- (LMU Univ. Hospital, Germany)
14:00-14:45
- Plenary Lecture 5
- 5
- Venue: RM 1(Vista 1+2)
Moderators
- Joon Jeong
- (Gangnam Severance Hospital, Korea)
Speakers
- Escalation and De-escalation of Breast Cancer Treatment
- Michael Gnant
- (Medical Univ. of Vienna, Austria)
15:00-16:15
- Symposium 6:
- The Role of Imaging in the Personalized Treatment11
- Venue: RM 1(Vista 1+2)
Moderators
- Woo Kyung Moon
- (Seoul National Univ. Hospital, Korea)
- Bo Kyoung Seo
- (Korea Univ. Ansan Hospital, Korea)
Speakers
- The Role of Imaging for the Management of DCIS
- Mami Iima
- (Kyoto Univ. Hospital, Japan)
- The Role of DW-MRI in the Personalized Screening and Diagnosis
- Savannah Partridge
- (Univ. of Washington, U.S.A.)
- Quantitative Imaging in Outcome Prediction of Breast Cancer
- Vivian Youngjean Park
- (Yonsei Univ. College of Medicine, Korea)
- Panel Discussion 5:
- Locoregional Treatment for Advanced/Recurrent Breast Cancer19
- Venue: RM 2(Vista 3)
Moderators
- Seung Ki Kim
- (CHA Bundang Medical Center, Korea)
- Andreas Karakatsanis
- (Uppsala Univ. Hospital, Sweden)
Speakers
- Surgical Extent After Neoadjuvant Chemotherapy
- Geok Hoon Lim
- (KK Women's and Children's Hospital, Singapore)
- Role of Repeat Breast-conserving Surgery for the Management of Ipsilateral Breast Cancer Recurrence
- Andreas Karakatsanis
- (Uppsala Univ. Hospital, Sweden)
- Radiation Therapy According to Residual Tumor Volume After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
- Sung-Ja Ahn
- (Chonnam National Univ. Medical School, Korea)
- Education Session 5:
- Liquid Biopsy: New Era of Cancer Management25
- Venue: RM 3(Walker Hall 1)
Moderators
- Keun Seok Lee
- (National Cancer Center, Korea)
- Kan Yonemori
- (National Cancer Center Hospital, Japan)
Speakers
- Basic Technology of Liquid Biopsy
- Eunhae Cho
- (GC Genome, Korea)
- Clinical Utility of Detection of Early Recurrence or Minimal Residual Disease Using Liquid Biopsy in Early Breast Cancer
- Kan Yonemori
- (National Cancer Center Hospital, Japan)
- Current Advances of Liquid Biopsy in Tumor Burden Dynamics, Response Monitoring and Prognostic Marker in Metastatic Breast Cancer
- Jisun Kim
- (ASAN Medical Center, Korea)
- Nursing Session 2 (Kor.):
- Living and Care as Women with Hereditary Breast Cancer34
- Venue: RM 5(Art Hall)
Moderators
- Mi Young Kang
- (Daerim St. Mary's Hospital, Korea)
- Insook Lee
- (Changwon National Univ., Korea)
Speakers
- An Overview of Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome
- Bom-Yi Lee
- (Daerim St. Mary's Hospital, Korea)
- Genetic Counseling for Hereditary Breast Cancer Patients
- Ji Hye Yang
- (ASAN Medical Center, Korea)
- The Process of Choosing Cancer Risk-reducing Options in Women with Hereditary Breast Cancer: A Grounded Theory Study
- Sun-Young Park
- (Daegu Catholic Univ., Korea)
15:00-16:40
- Endoscopic and Robotic Breast Surgery Session
- 29
- Venue: RM 4(Walker Hall 2)
Moderators
- Hyukjai Shin
- (Myongji Hospital, Korea)
- Jesse Selber
- (Corewell Health, U.S.A.)
Speakers
- Challenges of Robot Breast Surgery: Is there a Role for Robot Breast Surgery Outside of Clinical Trial?
- Moo Hyun Lee
- (Keimyung Univ. School of Medicine, Korea)
- Challenges of Endoscopic Breast Surgery: Is It Just a Bridge for Robot Breast Surgery?
- Chi Wei Mok
- (Changi General Hospital, Singhealth Duke NUS Breast Centre, Singapore)
- Current Status of Robot Breast Surgery
- Wen-Ling Kuo
- (Chang Gung Memorial Hospital, Taiwan)
- Robot Surgery for Breast Reconstruction
- Jesse Selber
- (Corewell Health, U.S.A.)
16:30-17:45
- Symposium 7:
- PMRT/RNI in the Modern Era12
- Venue: RM 1(Vista 1+2)
Moderators
- Chang-Ok Suh
- (CHA Bundang Medical Center, Korea)
- Kyubo Kim
- (Ewha Womans Univ. Mokdong Hospital, Korea)
Speakers
- Personalization of PMRT in the Modern Era
- Meena S. Moran
- (Yale School of Medicine, U.S.A.)
- The Benefit of PMRT for Low Nodal Burden Breast Cancer in the Modern Treatment Era
- Kyung Hwan Shin
- (Seoul National Univ. Hospital, Korea)
- Incorporation of New Systemic Agents in Patients Treated with PMRT
- Alice Ho
- (Duke Univ., U.S.A.)
- Debate Session
- 27
- Venue: RM 2(Vista 3)
Moderators
- Jae Ho Jeong
- (ASAN Medical Center, Korea)
Speakers
- Role of Platinum Agent in Early Triple Negative Breast Cancer - Pros.
- Jieun Lee
- (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
- Role of Platinum Agent in Early Triple Negative Breast Cancer - Cons.
- Min Hwan Kim
- (Yonsei Univ. College of Medicine, Korea)
- Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Genomic risk
- Dae-Won Lee
- (Seoul National Univ. Hospital, Korea)
- Genomic Risk vs. Clinical Risk in Early-stage, HR+ Breast Cancer - Clinical risk
- Tae-Kyung Robyn Yoo
- (ASAN Medical Center, Korea)
Panelist
- -
- Ian Krop
- (Yale School of Medicine, U.S.A.)
- Yeon Hee Park
- (Samsung Medical Center, Korea)
- Soo Chin Lee
- (National Univ. Cancer Institute, Singapore)
- Education Session 6:
- Post-operative Management and Surveillance Strategies for Breast Cancer Patients26
- Venue: RM 3(Walker Hall 1)
Moderators
- Tae Hyun Kim
- (Inje Univ. Busan Paik Hospital, Korea)
- An-Chieh Feng
- (Tri-Service General Hospital, Taiwan)
Speakers
- Surveillance Strategy Overview in Korea
- Hyeong-Gon Moon
- (Seoul National Univ. Hospital, Korea)
- Post-operative Surveillance and Management for Breast Cancer Patients in Taiwan
- An-Chieh Feng
- (Tri-Service General Hospital, Taiwan)
- The State-of-the-art Risk Prediction Tools and How They Apply to Asian Breast Cancer Screening Programs
- Jingmei Li
- (Genome Institute of Singapore, Singapore)
16:30-18:00
- ABCN Business Meeting & Networking
- 50
- Venue: RM 5(Art Hall)
Moderators
- Sung-Bae Kim
- (ASAN Medical Center, Korea)
Speakers
- Opening Remarks & Introduction: Mentoring for Mentors
- Sung-Bae Kim
- (ASAN Medical Center, Korea)
- Keynote Lecture
- Sibylle Loibl
- (GBG Forschungs GmbH, Germany)
- [Part 1] Expert Panel Discussion: Navigating Challenges and Building Synergies in Breast Cancer Research: Insights from Experienced Experts
- Hee Kyung Ahn
- (Gachon Univ. Gil Medical Center, Korea)
- Topic 1: The Art of Mentorship: Nurturing a Successful Career and Strategies for Effective Collaboration
- Kyung-Hun Lee
- (Seoul National Univ. Hospital, Korea)
- Topic 2: Beyond Borders: Leveraging International Networks and Overcoming Practical Obstacles
- Yoo Seok Kim
- (Chosun Univ. Hospital, Korea)
- [Part 2] Introduction
- Sung-Bae Kim
- (ASAN Medical Center, Korea)
- Proposal: Neoadjuvant Chemotherapy or Upfront Surgery in Clinically Node-positive, ER+HER2- Breast Cancer: A Multi-national Survey Study
- Sung Gwe Ahn
- (Gangnam Severance Hospital, Korea)
- Product: Knowledge, Attitudes, and Behaviors toward Fertility Preservation in Patients with Breast Cancer: A Cross-Sectional Survey of Physicians
- Hee Jeong Kim
- (ASAN Medical Center, Korea)
Panelist
- General Discussion (Feedback) & Wrap-up
- Sung-Bae Kim
- (ASAN Medical Center, Korea)
16:50-17:50
- OPBS Session
- 28
- Venue: RM 4(Walker Hall 2)
Moderators
- Eun-Kyu Kim
- (Seoul National Univ. Bundang Hospital, Korea)
- Visnu Lohsiriwat
- (Siriraj Hospital, Mahidol Univ., Thailand)
Speakers
- Oncoplastic Breast Surgery: Where are We?
- Ho Yong Park
- (Kyungpook National Univ. Chilgok Hospital, Korea)
- Advanced Surgical Technic for Successful OPBS in Breast Cancer
- Visnu Lohsiriwat
- (Siriraj Hospital, Mahidol Univ., Thailand)
- Evaluation of Breast Symmetry and Cosmesis for Dense Breast
- Jung Ho Lee
- (The Catholic Univ. of Korea Bucheon St. Mary's Hospital, Korea)
18:00-18:45
- Satellite Symposium 4:
- Novartis48
- Venue: RM 1(Vista 1+2)
Moderators
- Woochul Noh
- (Konkuk Univ. Medical Center, Korea)
Speakers
- Optimal and Sequential Treatment Strategy for HR+ HER2- aBC Patients for Longer and Better Life
- Keun Seok Lee
- (National Cancer Center, Korea)
